| Metric | Q3 2024 | Q2 2024 | Q3 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $57M | — | $51M | — | 11.6% |
| Op. Income | $31M | — | $29M | — | 5.6% |
| Gross Margin | 90.2% | — | 93.3% | — | -3.1pp |
| Net Margin | 58.5% | — | 17.0% | — | 41.5pp |
| EPS (Diluted) | $0.21 | — | $0.08 | — | 162.5% |
| Free Cash Flow | $64M | — | $42M | — | 52.0% |
| Item | Amount |
|---|---|
| REVENUE | $57M |
| Cost of Revenue | $6M |
| GROSS PROFIT | $52M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $6M |
| SG&A Expenses | $6M |
| Other Expenses | $14M |
| Operating Expenses | $21M |
| Cost & Expenses | $26M |
| OPERATING INCOME | $31M |
| Interest Income | $20M |
| Interest Expense | $8M |
| Other Income/Expenses | $2M |
| INCOME BEFORE TAX | $33M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $33M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $33M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $33M |
| D&A | $14M |
| EBIT | $42M |
| EBITDA | $56M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $57M |
| Cost of Revenue | $6M |
| GROSS PROFIT | $52M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $6M |
| SG&A Expenses | $6M |
| Other Expenses | $14M |
| Operating Expenses | $21M |
| Cost & Expenses | $26M |
| OPERATING INCOME | $31M |
| Interest Income | $20M |
| Interest Expense | $8M |
| Other Income/Expenses | $2M |
| INCOME BEFORE TAX | $33M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $33M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $33M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $33M |
| D&A | $14M |
| EBIT | $42M |
| EBITDA | $56M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $33M |
| Depreciation & Amortization | $13M |
| Stock-Based Compensation | $1M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $8M |
| Change in Working Capital | $12M |
| OPERATING CASH FLOW | $67M |
| Capital Expenditure | -$3M |
| Acquisitions (Net) | -$43M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$314M |
| NET CASH FROM INVESTING | -$359M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$45M |
| Other Financing Activities | $219M |
| NET CASH FROM FINANCING | $174M |
| FREE CASH FLOW | $64M |
| Net Change in Cash | -$118M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $377M |
| Short-Term Investments | $0 |
| Net Receivables | $881.0K |
| Inventory | $0 |
| Other Current Assets | $16M |
| TOTAL CURRENT ASSETS | $394M |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $2.5B |
| TOTAL NON-CURRENT ASSETS | $2.5B |
| TOTAL ASSETS | $2.9B |
| Account Payables | $50M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $99M |
| Long-Term Debt | $397M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $397M |
| TOTAL LIABILITIES | $496M |
| Common Stock | $2M |
| Additional Paid-In Capital | $3.0B |
| Retained Earnings | -$530M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.4B |
| Minority Interest | $3M |
| TOTAL EQUITY | $2.4B |
| TOTAL LIABILITIES & EQUITY | $2.9B |
| Total Debt | $397M |
| Net Debt | $20M |